Karla Robinson, MD and Medical Editor at GoodRx discusses how GLP-1 receptor agonists work and their benefits.

Kourtney Kardashian's new supplement, Lemme GLP-1 Daily, is marketed as a natural alternative to Ozempic, Wegovy, and ...

The popularity of the newest weight loss medications has employers reevaluating their health plans. There are a lot of unknowns, but here’s what we do know based on the data.

Two leading glucagon-like peptide-1 (GLP-1) receptor agonists for obesity and type 2 diabetes – Novo ... 2018 was “deliberately crafted” so that pre-revenue companies could list in Hong Kong, helping ...

Hims & Hers experienced a stock surge due to offering compounded GLP-1 agonist drugs at an 85% discount ... are both listed on FDA's Drug Shortages list. I gave Hims and Hers stock a "buy ...

These GLP-1 agonists, which were initially prescribed ... Like the other players on this list, GSK does have some weight loss drugs in its pipeline. But the focus among many investors is the ...

The company said that, based on a pharmacokinetic study, it has plumped for a once-daily, modified-release formulation of GLP-1 agonist danuglipron ... which has a long list of candidates in ...

Roche has reported early-stage clinical data with an oral GLP-1 agonist acquired as part of ... one of a lengthening list of pharma companies that are hoping to hit on effective 'me-too' products ...

For individuals with conditions such as type 2 diabetes or obesity, GLP-1 agonist medications like semaglutide (the ... they often come with a laundry list of side effects, including nausea, vomiting, ...